Bluesky feels like a shopping mall with too many of the same stores

I haven't been great about sharing here lately, but I have still been writing. This is from a couple of weeks ago: Why I Don't Often Mention Neuroscience (despite being a neuroscientist).

"This brought me hope,” a PRIMA patient said. “It literally changed my life.” Read more in @time.com time.com/7330887/brai...

Must-read #NYBCI25 coverage by @neurotechnology.substack.com in @forbes.com. My key takeaway on cognitive BCI: Our biggest limiting factor isn't tech—it's fundamental scientific understanding. We can’t advance the tech until we define the disorder. Basic research must lead the way!

petition to return to when online looked like this

An interesting study on biotech failure: open.substack.com/pub/age1/p/a...

Georgia Tech Is Teaching Other Universities a Fundraising Lesson — via @wsj.com + @nidhisubs.bsky.social www.wsj.com/us-news/educ...

Oeps, correct link is: rdcu.be/eCB2v

Neurotech futures

We are hiring electrical engineers, cell biologists and microfabrication engineers to join our founding team! We're looking for smart and caring people. If that's you please apply, or tag someone who is incredible. 🚀 🧠 axoneurotech.com/careers

The horrendous ads on the site that published this uninspired article are worse for people's privacy and well-being than any neurotech. But yes...neuroethics and neurorights *waves hands*

My cartoon in this weeks @newyorker.com

#Neurotech Notables #31: May 1-15, 2025 Partnership Bonanza! Also: Funding, Reg news, ethics discourse, cool videos, & more. Please Read, Favorite, Share, and Subscribe today! neurotechnology.substack.com/p/notables-31

Atlanta friends, I want to extend a special invitation to have you join us for a really unique event we're hosting on May 7 called "Wired Lives: Personal Stories of Brain Implants": neuro.gatech.edu/wired-lives-...

Trump proposes massive NIH budget cut and reorganization www.science.org/content/arti...

Which #neurotech #neuromodulation #bci practitioners can help me draw up a parallel R&D framework for the field?

Did you know that neuroscience played a key role in AI’s development? Artificial Intelligence: From Mind to Machine explores how brain research led to artificial neural networks, machine learning, and modern AI. Watch the documentary with #TheBrainPrize2024 winners: brainprize.org/winners/comp...

🗞️🧠⚙️ #NEUROTECH NOTABLES #29 $200 million in new capital New positive phase 2/3 readouts, regulatory wins, Newcos, emergence from stealth, new product launches, exec appointments, fresh market research and more: open.substack.com/pub/neurotec...

Trump officials’ decision to prioritize autism comes amid a broader slowdown in NIH funding for other initiatives. As of last week, NIH funding was lagging billions of dollars behind its traditional pace for research awards, including studies on cancer, heart disease, and mental health.

NIH cuts hurt companies like Motif Neurotech. We are fortunate to have resources for clinical trials, but companies relying on NIH are struggling. Every day new therapies are delayed, people suffer. 🙏 Dan Gilbert for speaking to us & raising awareness www.washingtonpost.com/business/202...

(Forbes) Inner Cosmos, outer expansion: psychiatric #BCI gears up for prime time www.forbes.com/sites/naveen... by @neurotechnology.substack.com; "the pill mimics transcranial magnetic stimulation, pulsing into specific targets in the dorsolateral prefrontal cortex"; #NeuroTech

I wrote about a psychiatric brain computer interface that has now been tested in 3 people. It's early, but after meeting many of the company's leaders, as well as a person in his second year of using the device, it seemed real to me. www.forbes.com/sites/naveen...

Neurotech Notables #28: With health agencies on fire, US leadership in neurotechnology will surely lose a step compared to before. The rebuild/repair era is still months, if not years away. Curious to see how leaders in the private sector respond. neurotechnology.substack.com/p/notables-28

The latest in our #NeuroAI series, from Eva Dyer and @tyrellturing.bsky.social , with comments from @clopathlab.bsky.social, @kordinglab.bsky.social, @memming.bsky.social, @pessoabrain.bsky.social, @computingnature.bsky.social, @sussillodavid.bsky.social and others

Not to toot my own horn, but Neuromatch's NeuroAI course is one of the best places to learn about this exciting area of neuroscience. Students and postdocs, apply!

I'm not great at promoting my work...but I published an analysis of fundraising activity in the #neurotech industry last week! $2.3 Billion into 129 Deals, by stage, category, market, geography and more. Give it a click. Subscribe for more! neurotechnology.substack.com/p/2024-fundi...

Great snapshot from @neurotechnology.substack.com on 2024 Neurotech funding! Link: open.substack.com/pub/neurotec...

@zecca.bsky.social thanks for the follow! Do you track any social impact ventures specific to health subsectors? Strategic philanthropy for derisking science and tech funding, public/private grant models, etc. Also, where did you get/render your profile pic? It is awesome!

SMH www.reuters.com/world/us/us-...

In a special edition of her “How to teach this paper” column, Ashley Juavinett @analog-ashley.bsky.social explains how to best educate students about how the business of scientific research actually works. www.thetransmitter.org/how-to-teach... #neuroskyence

Thanks to all of the NIHers and their friends who reached out to me. I am still here (DM me or Signal jeremymberg.78) I still have a very incomplete picture but based on what I have been told, the damage to NIH and to many wonderful people who work(ed) there is/was impossible for me to imagine 1/n

I've been told this is a LARGE number of FDAers, with the devices side being A LOT more impacted than drugs. CDRH was already very unstaffed for their responsibilities; their role is so important to ensure consumer confidence in the safety and efficacy of devices. www.statnews.com/2025/02/15/t...

Cancer is a real b*tch

I remember syrup sandwiches and crumb allowances

This is the most relevant article to NIH and research cuts I’ve seen. Imagine if this was today , how many people would be saying “Why are we studying Gila Monsters and their impact on diabetes ? That’s wasted money !” globalnews.ca/news/9793403...

SOME GOOD NEWS ABOUT NIH FUNDING Closed sessions of institute and center Advisory Counsel meetings are now permitted. This is where grant applications are discussed and approved for potential funding. Open sessions where there are public presentations and discussions are still not allowed.

So, what drives @ieeebrain.bsky.social anyway? Our 2024 Chair Metin Akay shared his vision for advancing #brain research and #neurotechnology through interdisciplinary #collaboration. Read how we're paving the way for #innovation now at: bit.ly/IEEEBrainVis... #neuroscience #neurotech

🧠⚙️ This week I spoke with a HS student and aspiring BCI neural engineer, a managed care consultant, an MD-PhD in a DBS postdoc, a neurologist-entrepreneur running a clinic, & 2 leaders at a TMS and a consumer neurotech startup. It is an exciting industry that is forming. We are in the early innings!

I’m inviting you to attend a conference May 7-8 at Georgia Tech called InterfaceNeuro (interfaceneuro.org), targeting the intersection of neuroscience, neuroengineering, clinical/translational research, neurotech industry, and individuals with lived experiences. Please share! #neuroskyence 🧠🧪

It’s so exciting to see all the newly funded ARIA Precision Neurotechnologies projects get announced! A full list can be found here: www.aria.org.uk/opportunity-...

We’re excited to announce the 18 teams we’re funding in Precision Neurotechnologies 🧠 They’ll work to unlock new ways to interface with the brain at the neural circuit level, with unprecedented precision. (1/3)

📰 Featured in The Guardian: With support from ARIA's investment in precision neurotechnologies, we’re thrilled to announce Forest Neurotech's role in the UK’s first NHS clinical trial of an ultrasound-powered whole-brain interface. 🧠

RIP David Lynch. Enjoy the weirdest afterlife. Legend.

(YouTube) IPO Market Watch: Review & analysis for #Cortigent www.youtube.com/watch?v=PpHv... "Is this a company that I would invest in? No, they're running out of cash, they had this device approved years ago and still no revenue, they got way more debt..." $CRGT #BCI #NeuroTech

I wanted to share my rationale for our recent comment in Nature BME proposing an application-based taxonomy for BCI (unrolled from LinkedIn): Why we should consider labeling BCI based on its intended use. open.substack.com/pub/brainjac...

Happy New Year ! What are your resolutions? I am trying to replace an hour of smartphone doomscrolling with one hour of daily reading.

#Neurotech Notables #22: Dec 2024 Over $180m in new funding+ handful of new dedicated neurotech funds + grant awards. Many positive new FDA decisions & new commercial partnerships to close out the year. Also: industry news on #BCI, TMS, PbM, & more! neurotechnology.substack.com/p/neurotech-...

Live demos are hard, letting anyone try out the demo is harder. Hardware makes all of this doubly so. Thank you to everyone who dropped by our posters, engaged in discussions, and tried out the surface EMG demo. We were humbled by the interest! #NeurIPS2024

Neuroimaging Is The Future of CNS Drug Development Inside Alto Neuroscience's Efforts to Revolutionize Clinical Trials https://buff.ly/4gfdyT9 Though many life sciences companies have placed early bets on digitization and decentralization, few have built their entire business model on it.

Teardown: Transcranial Magnetic Stimulation (July 2024) Commercially available in the US for over 20 years, the clinical evidence for patients is promising, but the economic evidence for populations is not. Not yet.